| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| SHV Management Services, LLC | 10%+ Owner | $3,399,963 | 13 Jun 2022 | ||
| Kevin M. Lalande | Director, 10%+ Owner | $2,489,047 | 27 Sep 2024 | ||
| BIOTECH TARGET N V | 10%+ Owner | $412,500 | 14 Nov 2024 | ||
| Sean McLennan | Chief Financial Officer (interim) and Treasurer | $14,100 | 16 Jun 2022 | ||
| Scott D. Morenstein | Director | 03 Jun 2021 | |||
| Roger J. Waltzman | Chief Medical Officer | 15 Feb 2023 | |||
| Jason S. Kim | Chief Financial Officer | 23 Jan 2024 | |||
| Jonathan Lanfear | Director | 27 Oct 2023 | |||
| Harold E. Selick | Director | 27 Sep 2024 | |||
| Gabriela Gruia | Director | 27 Sep 2024 | |||
| Eric E. Poma | Chief Executive Officer and Chief Scientific Officer, Director | 23 Jan 2024 | |||
| Maurizio Voi | Chief Medical Officer | 23 Jan 2024 | |||
| Corazon (corsee) D. Sanders | Director | 27 Sep 2024 | |||
| Dave Hoffmann | Director | 27 Sep 2024 | |||
| David Hirsch | Director | 03 Jun 2022 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||